rs149840356

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_033305.3(VPS13A):​c.4760A>G​(p.Tyr1587Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00828 in 1,613,384 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y1587S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0053 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0086 ( 70 hom. )

Consequence

VPS13A
NM_033305.3 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10O:1

Conservation

PhyloP100: 2.71

Publications

8 publications found
Variant links:
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
VPS13A Gene-Disease associations (from GenCC):
  • chorea-acanthocytosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_033305.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065418184).
BP6
Variant 9-77316303-A-G is Benign according to our data. Variant chr9-77316303-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 448864.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00527 (802/152172) while in subpopulation NFE AF = 0.00949 (645/67936). AF 95% confidence interval is 0.00889. There are 3 homozygotes in GnomAd4. There are 360 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033305.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13A
NM_033305.3
MANE Select
c.4760A>Gp.Tyr1587Cys
missense
Exon 39 of 72NP_150648.2Q96RL7-1
VPS13A
NM_001018037.2
c.4643A>Gp.Tyr1548Cys
missense
Exon 38 of 71NP_001018047.1Q96RL7-3
VPS13A
NM_015186.4
c.4760A>Gp.Tyr1587Cys
missense
Exon 39 of 69NP_056001.1Q96RL7-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13A
ENST00000360280.8
TSL:1 MANE Select
c.4760A>Gp.Tyr1587Cys
missense
Exon 39 of 72ENSP00000353422.3Q96RL7-1
VPS13A
ENST00000376636.7
TSL:1
c.4643A>Gp.Tyr1548Cys
missense
Exon 38 of 71ENSP00000365823.3Q96RL7-3
VPS13A
ENST00000643348.1
c.4760A>Gp.Tyr1587Cys
missense
Exon 39 of 69ENSP00000493592.1Q96RL7-2

Frequencies

GnomAD3 genomes
AF:
0.00527
AC:
802
AN:
152054
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00164
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00141
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00949
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00457
AC:
1149
AN:
251150
AF XY:
0.00476
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.00487
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00171
Gnomad NFE exome
AF:
0.00766
Gnomad OTH exome
AF:
0.00474
GnomAD4 exome
AF:
0.00860
AC:
12564
AN:
1461212
Hom.:
70
Cov.:
30
AF XY:
0.00833
AC XY:
6053
AN XY:
726888
show subpopulations
African (AFR)
AF:
0.00129
AC:
43
AN:
33448
American (AMR)
AF:
0.00119
AC:
53
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00640
AC:
167
AN:
26106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39642
South Asian (SAS)
AF:
0.00380
AC:
328
AN:
86232
European-Finnish (FIN)
AF:
0.00200
AC:
107
AN:
53406
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5764
European-Non Finnish (NFE)
AF:
0.0103
AC:
11446
AN:
1111536
Other (OTH)
AF:
0.00684
AC:
413
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
654
1308
1963
2617
3271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00527
AC:
802
AN:
152172
Hom.:
3
Cov.:
32
AF XY:
0.00484
AC XY:
360
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.00164
AC:
68
AN:
41558
American (AMR)
AF:
0.00229
AC:
35
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00415
AC:
20
AN:
4824
European-Finnish (FIN)
AF:
0.00141
AC:
15
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00949
AC:
645
AN:
67936
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
42
83
125
166
208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00675
Hom.:
9
Bravo
AF:
0.00480
Asia WGS
AF:
0.000867
AC:
3
AN:
3476
EpiCase
AF:
0.00786
EpiControl
AF:
0.00806

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
1
3
Chorea-acanthocytosis (5)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
17
DANN
Benign
0.88
DEOGEN2
Benign
0.28
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.73
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.79
T
MetaRNN
Benign
0.0065
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.51
N
PhyloP100
2.7
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.99
N
REVEL
Benign
0.069
Sift
Benign
0.13
T
Sift4G
Benign
0.093
T
Varity_R
0.064
gMVP
0.62
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs149840356;
hg19: chr9-79931219;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.